Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
Boehringer Ingelheim (Germany) · University of Cape Town · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
622
total citations
- FWCI
- 33.69
- Percentile
- 100%
- References
- 50
Citations per year
Authors
5- LWLutz WollinCorresponding
Boehringer Ingelheim (Germany), University of Cape Town, Centre National de la Recherche Scientifique, Université d'Orléans
- IMIsabelle Maillet
Centre National de la Recherche Scientifique, Université d'Orléans, Boehringer Ingelheim (Germany), University of Cape Town
- VQValérie Quesniaux
Boehringer Ingelheim (Germany), University of Cape Town, Centre National de la Recherche Scientifique, Université d'Orléans
- AHAlexander Holweg
Centre National de la Recherche Scientifique, Université d'Orléans, University of Cape Town, Boehringer Ingelheim (Germany)
- BRBernhard Ryffel
Boehringer Ingelheim (Germany), Centre National de la Recherche Scientifique, Université d'Orléans, University of Cape Town
Topics & keywords
Topics
Keywords
- Nintedanib
- Platelet-derived growth factor receptor
- Pulmonary fibrosis
- Fibrosis
- Bleomycin
- Idiopathic pulmonary fibrosis
- Bronchoalveolar lavage
- Medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.